Estimated market cap $9.69BShares outstanding from the company’s latest SEC filing (all share classes, each priced at its own close; ADRs converted to ADS) × last close from Tiingo. Updated daily. This figure: shares as of Aug 4, 2026, last close Nov 13, 2026.134.26M shares, shares as of Aug 4, 2026CIK 1237831The SEC’s Central Index Key, the number it uses to identify every company and person that files.
Insider trades, 12 mo
0 buys · 12 sells
$14.35M sold, open market
Congress trades, 24 mo
7
4 purchases, 3 sales
13F holders
…
Lobbying, 12 mo
—
No lobbying filings
Federal contracts, 12 mo
—
None matched
Ask your AI:
Latest 10-Q
What changed in Globus Medical, Inc.'s latest quarterly report, compared with the one before.
Loading…
Insider trades
Open-market trades from Form 4. 10b5-1 marks a plan set in advance.Open-market buys and sales by officers, directors and 10% owners, from SEC Form 4. A plan set in advance is marked 10b5-1.
Loading…
13F holders
Funds that report this stock, checked against market prices.Fund managers with over $100 million in US-listed stocks file a 13F each quarter, up to 45 days after quarter end. Long positions only.
Loading…
Top 10 holders.Premium lists every holder, with CSV downloads.
Disclosed in dollar ranges, up to 45 days after the trade.Members of Congress, their spouses and dependent children report trades in dollar ranges, up to 45 days after the trade.
Loading…
Lobbying
What Globus Medical, Inc. and its lobbying firms report each quarter.A company that lobbies with its own staff reports its expenses; a lobbying firm it hires reports the income it received. We count both.
Loading…
H-1B labor applications at Globus Medical, Inc.
33 certified in 12 mo
Labor condition applications decided by the Department of Labor, matched to Globus Medical, Inc. by employer name. An application is not a hire.
Median yearly wage offered, full-time certified applications, Jul 2025 to Jun 2026: $123,706The wage the employer offered, as filed, with its unit. The yearly figure restates it per year (hourly x 2,080, weekly x 52, every two weeks x 26, monthly x 12) from the low end of the offered range. It is not what the worker was paid.
H-1B labor applications decided at Globus Medical, Inc. by quarter
We match the employer's name to a public company automatically, including a reviewed list of subsidiaries. A subsidiary can be missed and a similar name can be matched wrongly. The files carry no worker names.
Institutional ownership over time
How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.
13F holders, Q3 2026Fund managers with over $100 million in US-listed stocks file a 13F each quarter, up to 45 days after quarter end. Long positions only.
446
65.5% of shares · 176 added
Latest 10-Q
Q3 2026
What changed in Globus Medical, Inc.'s latest quarterly report, compared with the one before.
Filed Nov 5, 2026 · Quarter ended Sep 30, 2026
Summary text goes here once it has loaded. Summary text goes here once it has loaded.
Summary text goes here once it has loaded.
Summary text goes here once it has loaded.
AI summary of changes vs the prior report. Written by AI from the paragraphs that changed, and checked against them. This is information, not investment advice.
Compared with the 10-Q for the quarter ended Jun 30, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.
Open-market trades from Form 4. 10b5-1 marks a plan set in advance.Open-market buys and sales by officers, directors and 10% owners, from SEC Form 4. A plan set in advance is marked 10b5-1.
Recent insider trades
How the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss.
446 funds report GMED. Values checked against market prices.Fund managers with over $100 million in US-listed stocks file a 13F each quarter, up to 45 days after quarter end. Long positions only.
Funds own 89% of shares (Q2 2026)Fund managers with more than $100 million in US-listed stocks file a 13F each quarter. It lists their long stock positions only (shorts, options and bonds are left out) and can arrive up to 45 days after the quarter ends, so this is a snapshot of the quarter end. We add up the shares every fund reports in this class and divide by the shares outstanding. The total can pass 100%: the same shares are often reported by more than one manager (an adviser and the fund it runs), lent shares can be reported twice, and the share count can be out of date after buybacks. We divided 119.40M reported shares by 134.26M shares, from the company’s SEC filing as of Aug 4, 2026.
599 funds hold the stock.
Q3 2026: 65% · 5,560 of ~8,900 funds reported so farFunds have 45 days after a quarter ends to file. This quarter’s reports are still arriving, so the figure only counts the funds that have filed so far and will usually rise.
Q2 202585%
Q3 202591%
Q4 202584%
Q1 202681%
Q2 202689%
Q3 2026 (so far)65%
Q3 2026. 62 new, 176 added to, 137 trimmed, 216 exited since Q2 2026.
Download CSVEvery fund that holds GMED, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Trades by members of Congress
7 in 24 mo
Disclosed in dollar ranges, up to 45 days after the trade.Members of Congress, their spouses and dependent children report trades in dollar ranges, up to 45 days after the trade.
Recent congressional trades
How the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss.
What Globus Medical, Inc. and its lobbying firms report each quarter.A company that lobbies with its own staff reports its expenses; a lobbying firm it hires reports the income it received. We count both.
No recent lobbying filings for this company.
Institutional ownership over time
How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.
Funds holding the stock
Shares they report
Funds holding the stock by quarter
Q2 2013
106
—
39.17M
$660.2M
Q3 2013
119
+13
53.06M
$926.5M
Q4 2013
134
+15
52.92M
$1.1B
Q1 2014
157
+23
53.68M
$1.4B
Q2 2014
174
+17
57.30M
$1.4B
Q3 2014
165
-9
57.74M
$1.1B
Q4 2014
183
+18
61.52M
$1.5B
Q1 2015
179
-4
62.72M
$1.6B
Q2 2015
178
-1
63.37M
$1.6B
Q3 2015
181
+3
66.86M
$1.4B
Q4 2015
190
+9
67.02M
$1.9B
Q1 2016
202
+12
72.27M
$1.7B
Q2 2016
208
+6
68.96M
$1.6B
Q3 2016
195
-13
65.08M
$1.5B
Q4 2016
206
+11
67.31M
$1.7B
Q1 2017
243
+37
67.12M
$2.0B
Q2 2017
244
+1
63.93M
$2.1B
Q3 2017
253
+9
68.79M
$2.0B
Q4 2017
263
+10
63.80M
$2.6B
Q1 2018
279
+16
61.94M
$3.1B
Q2 2018
289
+10
64.26M
$3.2B
Q3 2018
312
+23
67.72M
$4.2B
Q4 2018
302
-10
69.71M
$3.0B
Q1 2019
268
-34
67.07M
$3.3B
Q2 2019
259
-9
68.83M
$2.9B
Q3 2019
268
+9
68.93M
$3.5B
Q4 2019
307
+39
69.66M
$4.1B
Q1 2020
273
-34
73.63M
$3.1B
Q2 2020
322
+49
68.21M
$3.3B
Q3 2020
344
+22
64.39M
$3.2B
Q4 2020
348
+4
66.62M
$4.3B
Q1 2021
345
-3
67.75M
$4.2B
Q2 2021
354
+9
69.52M
$5.4B
Q3 2021
388
+34
67.97M
$5.2B
Q4 2021
372
-16
68.35M
$4.9B
Q1 2022
376
+4
71.11M
$5.2B
Q2 2022
364
-12
73.96M
$4.1B
Q3 2022
370
+6
82.85M
$4.9B
Q4 2022
390
+20
75.84M
$5.6B
Q1 2023
390
0
75.03M
$4.2B
Q2 2023
382
-8
81.43M
$4.8B
Q3 2023
431
+49
109.42M
$5.4B
Q4 2023
408
-23
110.70M
$5.9B
Q1 2024
438
+30
116.95M
$6.3B
Q2 2024
450
+12
116.85M
$8.0B
Q3 2024
449
-1
110.74M
$7.9B
Q4 2024
500
+51
108.94M
$9.0B
Q1 2025
515
+15
110.00M
$8.0B
Q2 2025
483
-32
115.21M
$6.8B
Q3 2025
493
+10
121.73M
$7.0B
Q4 2025
566
+73
112.27M
$9.8B
Q1 2026
610
+44
109.52M
$9.4B
Q2 2026
600
-10
119.40M
$9.5B
Q3 2026
446
-154
87.88M
$6.6B
Each point is a quarter-end, from Q2 2013 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.
Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.
The history follows the company's current CUSIP number (379577208). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q2 2013) can be later than the stock's first appearance in 13F reports.
Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.
A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.